Does the Decrease in Hormone Replacement Therapy Also Affect Breast Cancer Risk in the Netherlands?
- 1 November 2007
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (31) , 5038-5039
- https://doi.org/10.1200/jco.2007.13.7281
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Regional Changes in Hormone Therapy Use and Breast Cancer Incidence in California From 2001 to 2004Journal of Clinical Oncology, 2007
- The Decrease in Breast-Cancer Incidence in 2003 in the United StatesNew England Journal of Medicine, 2007
- Use of hormones in the menopausal transition period in the Netherlands between 1993 and 1997Maturitas, 2006
- Use of oral contraceptives and hormone replacement therapy in the WHO MONICA projectMaturitas, 2004
- Comparative quantification of health risks: Conceptual framework and methodological issuesPopulation Health Metrics, 2003
- Hormone replacement therapy and accuracy of mammographic screeningThe Lancet, 2000
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997